Synergistic Integration of Near IR Closed Chain Sulfo-Cyanine Dyes and Prostate Specific Membrane Antigen Ligands with Emerging Technologies

The inventive concept integrates near IR closed chain sulfo-cyanine dyes and prostate specific membrane antigen ligands with emerging technologies such as AI, IoT, blockchain, and novel materials to create a new, more powerful system for minimally invasive medical procedures, enhancing image analysis, diagnosis, and treatment outcomes.

The original patent addresses the need for minimally invasive medical techniques to reduce patient recovery time and discomfort. However, the patent's limitations include the lack of integration with emerging technologies, which hinders its potential for enhanced image analysis, diagnosis, and treatment outcomes. The new inventive concept solves this problem by synergistically combining the patented composition with distinct technologies to create a more powerful system.

The inventive concept comprises a composition of near IR closed chain sulfo-cyanine dyes and prostate specific membrane antigen ligands integrated with AI-powered medical imaging platforms, IoT-enabled sensors, blockchain-based secure data storage systems, and novel material-based delivery systems. The AI-powered platform enhances image analysis and diagnosis, while the IoT-enabled sensors provide real-time monitoring and tracking of the fluorescence signal. The blockchain-based system ensures secure storage and management of patient data, and the novel material-based delivery system enables targeted and controlled release of the composition. This synergistic integration enables a more accurate, efficient, and personalized approach to minimally invasive medical procedures.

The new inventive concept is novel and non-obvious compared to the original patent, as it introduces the integration of emerging technologies to create a more powerful system for minimally invasive medical procedures. The inventive step lies in the unexpected combination of the patented composition with distinct technologies, resulting in a system that is greater than the sum of its parts.

Alternative embodiments of the inventive concept could include the integration of other emerging technologies, such as machine learning, robotics, or virtual reality, to further enhance the system's capabilities. Variations of the composition and delivery system could also be explored to optimize the system's performance and versatility.

The inventive concept has significant commercial potential in the medical device and pharmaceutical industries, particularly in the areas of minimally invasive surgery, medical imaging, and personalized medicine. The target market includes hospitals, clinics, and medical research institutions, with potential for widespread adoption and significant revenue growth.